Stopping this DMT during pregnancy increases relapse-related disability risk
Stopping this DMT during pregnancy increases relapse-related disability risk Published: 08 February 2022 People with multiple sclerosis (MS) who stop taking Tysabri (natalizumab) during pregnancy have a significant risk of relapse-related disability, a new study has found. Researchers analysed data of 255 pregnant women from the German Multiple Sclerosis and